Pharmaceuticals

Bharat Parenterals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 65 filings·Updated 14 Oct 2026
Showing 10 of 65 filings.
14 Oct 20261 filing
Company UpdateNewspaper Publication

Submission of a copy of the newspaper advertisement dated October 14, 2026, informing shareholders about the dispatch of the corrigendum to the notice of EGM to be held on October 23, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 12:09View Source
13 Oct 20261 filing
AGM/EGMEGM

Corrigendum adds Monitoring Agency for Bharat Parenterals' proposed preferential equity issue at Oct 23 EGM

EGM purpose

  • EGM to seek shareholder approval for proposed preferential issue of equity shares.
  • Corrigendum adds disclosure on Monitoring Agency due to issue size.

Resolution details

  • Type: not disclosed; Nature: preferential issue of equity shares.
  • Key term: Crisil Ratings Limited appointed as Monitoring Agency for proceeds use.
  • Rationale: monitoring required when issue size exceeds INR 100 crore.
  • Promoters/directors' interest: not specified in corrigendum.
Filed 15:25View Source
2 Oct 20261 filing
Company UpdateNewspaper Publication

Newspaper publication for the 1st EGM of FY 2026-27.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 14:31View Source
29 Sept 20261 filing
Board MeetingOutcome of Board Meeting

Board approves preferential allotment of 9,12,759 equity shares at Rs 1,522.85; EGM planned

Preferential allotment details

  • Issuance of up to 9,12,759 equity shares at Rs 1,522.85 each for Rs 138.99 crore.
  • Non-promoter investors; subject to shareholder and regulatory approvals.
  • Annexure-1A sets out investors and post-allotment holdings.

EGM for approval

  • EGM scheduled for 23 October 2026 at 11:30 AM via video conference.
  • Shareholder approval for the preferential issue to be sought.

Investments in subsidiaries

  • Investments or loans to subsidiaries planned to support development of existing and new projects.

Regulatory/compliance notes

  • Subject to approvals under Companies Act 2013 and SEBI LODR.
Filed 16:22View Source
24 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Bharat Parenterals Limited: Trading Window closed from Oct 01, 2026 till completion of 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2026

Bharat Parenterals Limited: Trading Window closed from Oct 01, 2026 till completion of 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2026

Filed 17:14View Source
19 Sept 20262 filings
AGM/EGMAGM

Bharat Parenterals Ltd 33rd AGM: all six ordinary resolutions passed, including dividend and director changes

AGM details

  • AGM held Sep 19, 2026 via VC/OAVM from 11:00 to 11:30 IST.
  • Record date 12-09-2026; total on-record shareholders 3,108.
  • VC attendance: promoters 5, public 30.
  • Six resolutions were put to vote; all passed.

Resolutions & outcomes

  • Resolution 1: adoption of Audited Financial Statements; passed.
  • Resolution 2: declare final dividend for year ended Mar 31, 2026; passed.
  • Resolution 3: appoint Hemang Shah by rotation; reappointed as director; passed.
  • Resolution 4: reappoint Hemang Shah as Executive Director; passed.
  • Resolution 5: approve remuneration to CMA Chetan Gandhi for FY2027; passed.
  • Resolution 6: approve related party transactions; passed.

Dividend

  • Final dividend for FY ended 31 Mar 2026 approved; per-share amount not disclosed.

Director changes

  • Hemang Shah reappointed as Executive Director following rotation.

Auditors / Remuneration

  • Remuneration payable to CMA Chetan Gandhi, Cost Accountant, approved for FY ending Mar 31, 2027.

Related party transactions

  • Related Party Transactions approved.
Filed 16:57View Source
AGM/EGMAGM

AGM 2026: All resolutions passed including dividend, director appointments, remuneration, and related party transactions

AGM Details

  • AGM held on Sept 19, 2026 at 11:00 A.M. via VC/OAVM; concluded 11:30 A.M.

Key Resolutions

  • Ordinary resolution: adopt audited financial statements for year ended March 31, 2026.
  • Ordinary resolution: declare final dividend for year ended March 31, 2026.
  • Ordinary resolution: re-appoint Hemang Shah after retirement by rotation.
  • Ordinary resolution: re-appoint Hemang Shah as Executive Director.
  • Ordinary resolution: approve remuneration for CMA Chetan Gandhi for FY ending March 31, 2027.
  • Ordinary resolution: approve related party transactions.

Voting Outcome

  • All resolutions deemed to be passed on the AGM date.
Filed 13:51View Source
14 Sept 20261 filing
Company UpdateNewspaper Publication

Public Notice for Newspaper advertisement dated September 12, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:06View Source
28 Aug 20261 filing
Company UpdateNewspaper Publication

Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:25View Source
27 Aug 20261 filing
Company UpdateGeneral

Bharat Parenterals informs unregistered-email shareholders of AGM notice and FY2025-26 AR

Shareholder communications & AGM notice

  • Dispatched letters to shareholders with unregistered emails linking to FY2025-26 Annual Report and AGM notice.
  • 33rd AGM scheduled for Sep 19, 2026 at 11:00 IST via VC/OAVM; venue deemed to be Registered Office.
  • Annual Report for FY2025-26 available on the company's website and notices accessible there.
  • Cut-off date for voting entitlement: Sep 12, 2026.
  • Encourages email registration/update with depositories/RTA; dematerialization recommended for physical holders.
  • Nominations and KYC forms available on the website.
  • RTA contact email provided for queries.
Filed 17:17View Source
Showing 10 of 65 filings